Iceland

Diabetes estimates (20-79 y)
People with diabetes, in 1,000s	3.6	8.6	21.9	28.9
Age-standardised prevalence of diabetes, %	-	3.2	6.9	8.2
Proportion of people with undiagnosed diabetes, %	-	-	28.5	-
People with undiagnosed diabetes, in 1,000s	-	-	6.3	-

Impaired Fasting Glucose (IFG)
People with IFG, in 1,000s	-	-	14.2	16.7
Age-standardised prevalence of IFG, %	-	-	5.0	5.3

Impaired Glucose Tolerance (IGT)
People with IGT, in 1,000s	-	19.2	25.7	32.3
Age-standardised prevalence of IGT, %	-	7.6	8.5	9.7

Mortality attributable to diabetes (20-79 y)
Deaths attributable to diabetes	-	56.0	165.5	-
Proportion of diabetes-related deaths in people 20-79 y, %	-	-	14.8	-

Hyperglycaemia in pregnancy (HIP) (20-49 y)
Live births affected by HIP	-	-	-	-
Prevalence of gestational diabetes mellitus (GDM), %	-	-	-	-
Live births affected by other types of diabetes first detected in pregnancy	-	-	-	-
Live births affected by other types of diabetes detected prior to pregnancy	-	-	-	-

Diabetes-related health expenditure
Total diabetes-related health expenditure, USD million	-	-	176.7	192.5
Total diabetes-related health expenditure, ID million	-	-	138.3	150.7
Diabetes-related health expenditure per person, USD	-	6,278.0	8,054.8	6,661.1
Diabetes-related health expenditure per person, ID	-	-	6,306.3	5,215.1

Type 1 diabetes estimates in children and adolescents
People with type 1 diabetes (all age groups)	-	-	1,406.0	-
People with type 1 diabetes (0-19 y)	-	-	152.2	-

Demographics
Total adult population (20-79 y), in 1,000s	187.0	222.2	271.8	293.9
Population of children and adolescents (0-19 y)	-	-	94,865.5	-